Asthma management focuses on helping patients to maintain control of their disease. Here are some patient profiles that highlight the type of patients our medicines are designed to support.
Wheezing is starting to impact her life. She stays at home more and more, despite ICS maintenance therapy.
Night-time awakenings make it hard to focus on school. And when with friends, he often misses his second ICS dose.
Here you can watch expert perspectives, download valuable tools for use in your clinical practice and order from a range of free training devices.
ACT, Asthma Control Test; ICS, inhaled corticosteroid
Relvar Ellipta is indicated for the regular treatment of asthma in adults and adolescents aged 12 years and older where use of a combination medicinal product (long-acting beta2-agonist and inhaled corticosteroid) is appropriate: 1
- Patients not adequately controlled with inhaled corticosteroids and 'as needed' inhaled short-acting beta2-agonists
- Patients already adequately controlled on both inhaled corticosteroid and long-acting beta2-agonist